Dutch drug regulator and HTA body offer integrated scientific advice
This article was originally published in SRA
Executive Summary
The Netherlands has launched a year-long pilot programme allowing drug companies to seek "integrated" scientific advice from the Medicines Evaluation Board and the Healthcare Insurance Board (CVZ)1.